[
    {
        "answer": "Initial interpretation claimed 0.01% similarity between healthy individuals at the DNA sequence level.",
        "false_answer": "Initial interpretation claimed 0.01% similarity between healthy individuals at the DNA sequence level.",
        "incorrect_explanation": "The statement incorrectly mentions \"similarity\" instead of \"difference,\" and also inaccurately represents the percentage. According to the paragraph, there's a 99.9% similarity, implying that only 0.1% of the genome sequence accounts for individual differences in phenotype, not 0.01%.",
        "question": "What percentage of the human genome sequence accounts for individual differences in phenotype according to initial interpretations after the Human Genome Project was declared complete?",
        "source": {
            "isbn": "978-0323653992",
            "page": 35,
            "paragraph_id": "978-0323653992-p35-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 70%",
        "false_answer": "Approximately 70%",
        "incorrect_explanation": "According to the paragraph, approximately 10% to 20% of individuals with Turner syndrome have a structural abnormality of the X chromosome.",
        "question": "What percent of individuals with Turner syndrome have a structurally abnormal X chromosome?",
        "source": {
            "isbn": "978-0323653992",
            "page": 43,
            "paragraph_id": "978-0323653992-p43-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "There is approximately a 10% residual risk of fetal aneuploidy despite having a normal cfDNA result.",
        "false_answer": "Approximately a 10% residual risk of fetal aneuploidy despite having a normal cfDNA result.",
        "incorrect_explanation": "According to the paragraph, when conventional screening tests lead to invasive diagnostic testing results indicating abnormalities, there's mention of a residual risk associated with certain conditions. Specifically, for those electing to undergo cfDNA screening before diagnostic testing following positive conventional screening results, they should be counseled regarding a 2% residual risk of fetal aneuploidy with a normal cfDNA result. Therefore, the statement claiming a 10% residual risk is incorrect because the actual cited residual risk with a normal cfDNA result is much lower at 2%.",
        "question": "What is the estimated residual risk of fetal aneuploidy after receiving a normal cfDNA result?",
        "source": {
            "isbn": "978-0323653992",
            "page": 49,
            "paragraph_id": "978-0323653992-p49-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The pudendal nerve arises from the first, second, and third sacral roots.",
        "false_answer": "The pudendal nerve arises from the first, second, and third sacral roots.",
        "incorrect_explanation": "According to the provided information, the pudendal nerve actually arises from the second, third, and fourth sacral roots, not the first, second, and third.\n- **Correct Answer Should Be:** The pudendal nerve arises from the second, third, and fourth sacral roots.",
        "question": "What sacral roots give rise to the pudendal nerve?",
        "source": {
            "isbn": "978-0323653992",
            "page": 82,
            "paragraph_id": "978-0323653992-p82-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The diameter is generally reported to be between 4 mm and 6 mm.",
        "false_answer": "The diameter of the endocervical canal is between 4 mm and 6 mm.",
        "incorrect_explanation": "According to the given paragraph, the actual diameter varies but is specifically noted to be around 7 mm at its widest point, which suggests the statement of being between 4 mm and 6 mm underrepresents the size described in the text. Therefore, the correct understanding should reflect measurements consistent with what is detailed regarding variations and averages presented.",
        "question": "What is the typical range of the diameter of the endocervical canal?",
        "source": {
            "isbn": "978-0323653992",
            "page": 68,
            "paragraph_id": "978-0323653992-p68-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Up to 8 cm long.",
        "false_answer": "Up to 8 cm long.",
        "incorrect_explanation": "According to clinical practices, a normal ovary may be up to 5 cm long before menopause. Therefore, stating that a normal ovary can be up to 8 cm long introduces an inaccurate dimension regarding ovarian size during the reproductive years.",
        "question": "What is typically the maximum length of a normal ovary before menopause?",
        "source": {
            "isbn": "978-0323653992",
            "page": 76,
            "paragraph_id": "978-0323653992-p76-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Progesterone increases the frequency of GnRH pulses.",
        "false_answer": "Progesterone increases the frequency of GnRH pulses.",
        "incorrect_explanation": "According to the paragraph, progesterone actually slows down the frequency of GnRH pulses during the luteal phase, rather than increasing them.",
        "question": "What effect does progesterone have on GnRH pulse frequency during the luteal phase?",
        "source": {
            "isbn": "978-0323653992",
            "page": 105,
            "paragraph_id": "978-0323653992-p105-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The median effect of decision aids on length of consultation was 10 minutes longer.",
        "false_answer": "The median effect of decision aids on length of consultation was 10 minutes longer.",
        "incorrect_explanation": "The actual finding by Stacey in 2017 was that the median effect of decision aids on length of consultation was 2.6 minutes longer (24 vs. 21 minutes), representing a 7.5% increase, not 10 minutes longer.",
        "question": "What is the recommended increase in consultation length when using decision aids, according to Stacey's findings in 2017?",
        "source": {
            "isbn": "978-0323653992",
            "page": 138,
            "paragraph_id": "978-0323653992-p138-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "In 1999, Cochrane noted this issue.",
        "false_answer": "1999",
        "incorrect_explanation": "According to the text, Cochrane actually noted the issue in 1971.\n- **Correct Answer Should Be:** 1971",
        "question": "What year did Cochrane note the issue regarding measurements based on RCTs?",
        "source": {
            "isbn": "978-0323653992",
            "page": 127,
            "paragraph_id": "978-0323653992-p127-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Any pus expressed from the urethra should be discarded because it occasionally contains gonorrhea.",
        "false_answer": "Discarding any pus expressed from the urethra.",
        "incorrect_explanation": "According to the paragraph, any pus expressed from the urethra should actually be submitted for pathologic testing with culture and Gram staining because it is occasionally found to contain gonococci, indicating infection, rather than being discarded.",
        "question": "What action is taken with any pus expressed from the urethra during examination?",
        "source": {
            "isbn": "978-0323653992",
            "page": 153,
            "paragraph_id": "978-0323653992-p153-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The CDC recommends 1 hour of moderate-intensity aerobic activity per week.",
        "false_answer": "The CDC recommends 1 hour of moderate-intensity aerobic activity per week.",
        "incorrect_explanation": "The actual recommendation according to the CDC is 2.5 hours of moderate-intensity aerobic activity per week, which indicates the provided answer significantly underrepresents the suggested level of physical activity.",
        "question": "What does the CDC recommend for minimum weekly exercise duration for individuals aged 18-64 who engage in moderate-intensity aerobic activity?",
        "source": {
            "isbn": "978-0323653992",
            "page": 158,
            "paragraph_id": "978-0323653992-p158-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Women with end-stage renal disease go through menopause at an average age of 50.",
        "false_answer": "Women with end-stage renal disease go through menopause at an average age of 50.",
        "incorrect_explanation": "According to the paragraph, women who are on hemodialysis, with chronic renal disease, and those who have had renal transplants go through menopause at an earlier age, specifically 47 compared with 51 in women not undergoing dialysis. Therefore, the statement that they go through menopause at 50 is incorrect because it inaccurately represents the comparative ages given in the text.\n- **What the Correct Answer Should Be:** Women with end-stage renal disease go through menopause at an average age of 47, which is earlier than women not undergoing dialysis.",
        "question": "What is the average age at which women with end-stage renal disease go through menopause?",
        "source": {
            "isbn": "978-0323653992",
            "page": 166,
            "paragraph_id": "978-0323653992-p166-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "In 2017, approximately 19.4% of men and 14.2% of women reported past-year use of marijuana.",
        "false_answer": "Approximately 19.4% of men and 14.2% of women.",
        "incorrect_explanation": "According to the paragraph, in 2017, past-year use was actually reported by 17.8% of men and 12.5% of women. Therefore, the percentages given in the answer are higher than those specified in the paragraph, making them incorrect.",
        "question": "What percentage of women reported past-year marijuana use in 2017?",
        "source": {
            "isbn": "978-0323653992",
            "page": 190,
            "paragraph_id": "978-0323653992-p190-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "During the final stage of uterine septum resection, sharp dissection methods are preferred to ensure complete removal of the septal tissue.",
        "false_answer": "Sharp dissection methods are preferred during the final stage of uterine septum resection.",
        "incorrect_explanation": "According to the description provided, after initially resecting most of the septum using a bipolar electrode, the procedure involves avoiding the cutting of intraseptal blood vessels, indicating caution rather than preferring sharp dissections at this delicate stage. Instead, the method described uses blunt scissors for the final portion to minimize damage, suggesting careful handling to preserve surrounding tissues.",
        "question": "What is typically avoided during the final stages of resecting a uterine septum?",
        "source": {
            "isbn": "978-0323653992",
            "page": 221,
            "paragraph_id": "978-0323653992-p221-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 10% of woman aged 40 to 60 years reported a history of sexual assault.",
        "false_answer": "Approximately 10% of woman aged 40 to 60 years reported a history of sexual assault.",
        "incorrect_explanation": "According to the given text, among woman aged 40 to 60 years, 22% reported a history of sexual assault, which significantly differs from the claimed 10%.\n- **Correct Answer Should Be:** Among woman aged 40 to 60 years, approximately 22% reported a history of sexual assault.",
        "question": "What percent of women aged 40 to 60 years reported experiencing sexual assault?",
        "source": {
            "isbn": "978-0323653992",
            "page": 201,
            "paragraph_id": "978-0323653992-p201-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 50% of women.",
        "false_answer": "Approximately 50%",
        "incorrect_explanation": "According to the paragraph, Hilberman and Monson's classic study demonstrated that 25%, not 50%, of women treated for injuries in an emergency room were victims of wife battering.\n- **Correct Answer Should Be:** 25%",
        "question": "What percentage of women treated for injuries in an emergency room were victims of wife battering according to Hilberman and Monson's study?",
        "source": {
            "isbn": "978-0323653992",
            "page": 207,
            "paragraph_id": "978-0323653992-p207-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Worldwide Prevalence of Non-Coital Sexual Assault.",
        "false_answer": "Worldwide Prevalence of Non-Coital Sexual Assault",
        "incorrect_explanation": "The actual title refers specifically to \"non-partner sexual violence,\" which encompasses more than just non-coital acts and includes any form of sexual assault outside of intimate partner relationships. Therefore, the correct title is indeed \"Worldwide prevalence of non-partner sexual violence.\"",
        "question": "What was the title of the systematic review published by Abrahams et al. regarding non-partner sexual violence worldwide?",
        "source": {
            "isbn": "978-0323653992",
            "page": 213,
            "paragraph_id": "978-0323653992-p213-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The duration of the disturbance is more than 6 months.",
        "false_answer": "The duration of the disturbance is more than 6 months.",
        "incorrect_explanation": "According to Criterion F, the duration of the disturbance (Criteria B, C, D, and E) is actually more than 1 month, not 6 months. Therefore, the statement provided in the answer is incorrect because it inaccurately extends the minimum duration requirement.",
        "question": "What is the minimum duration for the disturbance caused by PTSD, as specified in Criterion F?",
        "source": {
            "isbn": "978-0323653992",
            "page": 186,
            "paragraph_id": "978-0323653992-p186-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Women aged 70 to 79 years.",
        "false_answer": "Women aged 70 to 79 years.",
        "incorrect_explanation": "According to the PRESIDE study data mentioned in the paragraph, low sexual desire accompanied by personal distress occurs in approximately 10% of women aged 30 to 39 years, 11% in those aged 40 to 49 years, 13% in those aged 50 to 59 years, and 10% in those aged 60 to 69 years. There is no mention of the prevalence rate specifically for the age group 70 to 79 years being around 10%.\n- **Correct Answer Should Be:** One of the specified age ranges within the study's findings, such as 30 to 39 years, which shows a prevalence of approximately 10%.",
        "question": "What age range experiences low sexual desire accompanied by personal distress in approximately 10% of women?",
        "source": {
            "isbn": "978-0323653992",
            "page": 194,
            "paragraph_id": "978-0323653992-p194-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The intraabdominal CO2 pressure should be greater than 15 mm.",
        "false_answer": "The intraabdominal CO2 pressure should be greater than 15 mm.",
        "incorrect_explanation": "According to the paragraph, the intraabdominal CO2 pressure as measured with the Verres needle should be less than 10 mm, indicating proper intraperitoneal placement. A higher CO2 pressure suggests inadvertent preperitoneal placement or other issues. Therefore, the correct answer should reflect pressures being less than 10 mm, not greater than 15 mm.",
        "question": "What is the recommended intraabdominal CO2 pressure as measured with the Verres needle during laparoscopic entry?",
        "source": {
            "isbn": "978-0323653992",
            "page": 229,
            "paragraph_id": "978-0323653992-p229-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "O'Hanlan KA led the study assessing educational impacts of interactive hysterectomy trainers on residents.",
        "false_answer": "O'Hanlan KA led the study assessing educational impacts of interactive hysterectomy trainers on residents.",
        "incorrect_explanation": "According to the given sources, Walker JL et al. were involved with the study concerning recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer, specifically through their work titled \"Gynecology Oncology Group Study LAP2.\" Meanwhile, Lichtman AS et al. worked on evaluating the impact of computerized interactive hysteria-trainers on education among gynecology residents, which indicates that neither of these studies was associated with O'Hanlan KA's contributions listed here.",
        "question": "Who conducted research comparing laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer?",
        "source": {
            "isbn": "978-0323653992",
            "page": 236,
            "paragraph_id": "978-0323653992-p236-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The odds ratio for preterm birth less than 34 weeks in women with a uterine anomaly was reported to be approximately 10.",
        "false_answer": "The odds ratio for preterm birth less than 34 weeks in women with a uterine anomaly was reported to be approximately 10.",
        "incorrect_explanation": "This answer is incorrect because according to the provided text, the study by Hua (2011) actually found the odds ratio for preterm birth less than 34 weeks in women with a uterine anomaly to be 7.4, not 10.",
        "question": "What is the estimated odds ratio for preterm birth less than 34 weeks in women with a uterine anomaly?",
        "source": {
            "isbn": "978-0323653992",
            "page": 251,
            "paragraph_id": "978-0323653992-p251-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Children through early adulthood.",
        "false_answer": "Children through early adulthood.",
        "incorrect_explanation": "The chapter specifically mentions considering gynecologic diseases of children from infancy through adolescence, indicating the focus is before reaching reproductive maturity rather than extending into early adulthood.\n- **Correct Answer Should Be:** Infancy through adolescence.",
        "question": "What age range does the chapter consider when discussing congenital anomalies?",
        "source": {
            "isbn": "978-0323653992",
            "page": 257,
            "paragraph_id": "978-0323653992-p257-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Motile sperm will be present in the prepubertal vagina for up to 48 hours.",
        "false_answer": "Up to 48 hours",
        "incorrect_explanation": "The paragraph actually states that motile sperm will be present in the prepubertal vagina for approximately 8 hours, making the claim of up to 48 hours inaccurate.\n- **Correct Answer Should Be:** Approximately 8 hours",
        "question": "How long do motile sperm typically remain in the prepubertal vagina after an incident?",
        "source": {
            "isbn": "978-0323653992",
            "page": 269,
            "paragraph_id": "978-0323653992-p269-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Not available",
        "false_answer": "N/A",
        "incorrect_explanation": "Due to lack of input data.\n- **What the Correct Answer Should Be:** Cannot determine at present time.",
        "question": "Not available",
        "source": {
            "isbn": "978-0323653992",
            "page": 264,
            "paragraph_id": "978-0323653992-p264-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Black and Hispanic women typically enter menopause approximately 5 years earlier than white women.",
        "false_answer": "Black and Hispanic women typically enter menopause approximately 5 years earlier than white women.",
        "incorrect_explanation": "According to the provided paragraph, black and Hispanic women have been found to have menopause approximately 2 years earlier than white women, not 5 years.\n- **Correct Answer Should Be:** Approximately 2 years earlier.",
        "question": "At what average age do black and Hispanic women experience menopause compared to white women?",
        "source": {
            "isbn": "978-0323653992",
            "page": 293,
            "paragraph_id": "978-0323653992-p293-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "AMH becomes undetectable 3 years before the final menstrual period.",
        "false_answer": "AMH becomes undetectable 3 years before the final menstrual period.",
        "incorrect_explanation": "This claim contradicts the finding from Sowers et al. (2008) referenced in Fig. 14.8, which indicates that AMH actually decreases to undetectable levels 5 years before the final menstrual period, not 3 years.",
        "question": "How many years before the final menstrual period does Anti-M\u00fcllerian Hormone (AMH) typically become undetectable?",
        "source": {
            "isbn": "978-0323653992",
            "page": 299,
            "paragraph_id": "978-0323653992-p299-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "A 30% to 50% protective effect against coronary atherosclerosis.",
        "false_answer": "A 30% to 50% protective effect.",
        "incorrect_explanation": "The paragraph actually mentions a 50% to 70% protective effect against coronary atherosclerosis when estrogen is begun at the time of oophorectomy, with or without an atherogenic diet. Therefore, the correct answer should reflect this higher range of protection.",
        "question": "What was the observed protective effect against coronary atherosclerosis when estrogen therapy was initiated at the time of oophorectomy in monkey models?",
        "source": {
            "isbn": "978-0323653992",
            "page": 311,
            "paragraph_id": "978-0323653992-p311-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 30% of the participants identified as Caucasian.",
        "false_answer": "Approximately 30% of the participants identified as Caucasian.",
        "incorrect_explanation": "The paragraph actually states that Caucasians made up 46.5% of the total study population, not 30%. Therefore, the correct answer should reflect this higher percentage.",
        "question": "What percentage of the total study population in the SWAN study identified as Caucasian?",
        "source": {
            "isbn": "978-0323653992",
            "page": 303,
            "paragraph_id": "978-0323653992-p303-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "A blood level of 40 ng/mL.",
        "false_answer": "A blood level of 40 ng/mL.",
        "incorrect_explanation": "According to the given information, a blood level of 25-hydroxyvitamin D (25[OH]D) less than 30 ng/mL usually warrants supplemental treatment, making the statement about 40 ng/mL incorrect.\n- **Correct Answer Should Be:** Less than 30 ng/mL.",
        "question": "What level of vitamin D does a blood test usually warrant supplemental treatment?",
        "source": {
            "isbn": "978-0323653992",
            "page": 309,
            "paragraph_id": "978-0323653992-p309-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "1999",
        "false_answer": "1999",
        "incorrect_explanation": "The publication year given in the passage is actually 2000, which indicates when Rigggs BL.'s study was released.\n- **Correct Answer Should Be:** 2000",
        "question": "What year was Rigggs BL.'s study published?",
        "source": {
            "isbn": "978-0323653992",
            "page": 334,
            "paragraph_id": "978-0323653992-p334-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Full breast development usually occurs between ages 14 to 17 years.",
        "false_answer": "Full breast development usually occurs between ages 14 to 17 years.",
        "incorrect_explanation": "According to the provided information, full breast development actually usually occurs by age 18 to 21 years. Therefore, stating that it happens earlier, specifically between ages 14 to 17 years, introduces a factual error regarding the typical timeline for complete breast maturation.",
        "question": "What age range typically marks full breast development?",
        "source": {
            "isbn": "978-0323653992",
            "page": 340,
            "paragraph_id": "978-0323653992-p340-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "A dose of 1200 mg.",
        "false_answer": "A dose of 1200 mg.",
        "incorrect_explanation": "According to the paragraph, if doses of gabapentin are titrated up to 2400 mg, the efficacy has been shown to be similar to that of CEE at 0.625 mg, indicating the effective comparison was made at this higher dose, not 1200 mg.",
        "question": "What dosage of gabapentin has been found to have efficacy similar to CEE at 0.625 mg?",
        "source": {
            "isbn": "978-0323653992",
            "page": 324,
            "paragraph_id": "978-0323653992-p324-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 25%.",
        "false_answer": "Approximately 25%.",
        "incorrect_explanation": "According to the given information, the actual percentage of women older than 60 who present with nipple discharge alone and have an underlying malignancy is 32%, not 25%. Therefore, the statement contains a factual error regarding the specified age group's likelihood of having an underlying malignancy when presenting with nipple discharge.",
        "question": "What percentage of women older than 60 with nipple discharge as their only presenting symptom likely have an underlying malignancy?",
        "source": {
            "isbn": "978-0323653992",
            "page": 345,
            "paragraph_id": "978-0323653992-p345-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Women who inherit a BRCA2 mutation have approximately a 35% to 60% risk of breast cancer.",
        "false_answer": "Approximately 35% to 60%.",
        "incorrect_explanation": "According to the given text, women with a BRCA2 gene mutation actually have a 45% to 70% risk of breast cancer to age 70.\n- **Correct Answer Should Be:** A woman inheriting a BRCA2 mutation faces a risk between 45% and 70% of developing breast cancer up to age 70.",
        "question": "What is the estimated risk range for women developing breast cancer if they have inherited a deleterious BRCA2 mutation?",
        "source": {
            "isbn": "978-0323653992",
            "page": 350,
            "paragraph_id": "978-0323653992-p350-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The American College of Cardiology employs the Mammographic Imaging Reporting and Data System.",
        "false_answer": "The American College of Cardiology employs the Mammographic Imaging Reporting and Data System.",
        "incorrect_explanation": "This statement incorrectly identifies the organization responsible for employing the reporting system for mammography findings. According to the given information, it is actually the American College of Radiology that uses the Breast Imaging Reporting and Data System (BI-RADS), not the American College of Cardiology.",
        "question": "What system does the American College of Radiology employ for mammography findings?",
        "source": {
            "isbn": "978-0323653992",
            "page": 357,
            "paragraph_id": "978-0323653992-p357-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Nearly 1 in 20 monosomy X gestations will survive to viability.",
        "false_answer": "Nearly 1 in 20 monosomy X gestations will survive to viability.",
        "incorrect_explanation": "According to the given information, nearly 1 in 300 monosomy X gestations will survive to viability, not 1 in 20. Therefore, the statement significantly overestimates the survival rate of monosomy X gestations.",
        "question": "What percentage of monosomy X gestations typically survive to viability?",
        "source": {
            "isbn": "978-0323653992",
            "page": 377,
            "paragraph_id": "978-0323653992-p377-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 25% of patients with RPL may have APLS.",
        "false_answer": "Approximately 25% of patients with RPL may have APLS.",
        "incorrect_explanation": "The paragraph actually suggests that APLS may be present in 5% to 15% of patients with RPL, according to Reindollar (2000).\n- **Correct Answer Should Be:** Between 5% and 15%.",
        "question": "What percentage of patients with Recurrent Pregnancy Loss (RPL) may have Antiphospholipid Syndrome (APLS)?",
        "source": {
            "isbn": "978-0323653992",
            "page": 382,
            "paragraph_id": "978-0323653992-p382-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Women under the age of 50 do not need regular screenings.",
        "false_answer": "Women under the age of 50 do not need regular screenings.",
        "incorrect_explanation": "Many health organizations, including the American College of Radiology and the Society of Breast Imaging, recommend annual screening starting at least by age 40. Some even suggest beginning at age 35 for those considered high risk.\n- **Correct Information Based on Standard Guidelines Would Be More Appropriate Here:** Generally, the recommendation is for average-risk women to begin routine mammogram screenings between ages 40 to 55, depending on various factors and guidelines from different professional societies.",
        "question": "What age range does the American College of Obstetricians and Gynecologists recommend average-risk women start undergoing regular mammograms?",
        "source": {
            "isbn": "978-0323653992",
            "page": 370,
            "paragraph_id": "978-0323653992-p370-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "About 10% of subsequent pregnancies are ectopic.",
        "false_answer": "About 10% of subsequent pregnancies are ectopic.",
        "incorrect_explanation": "According to the paragraph, the actual rate is much higher. For women who conceive after having one ectopic pregnancy, about 25% of subsequent pregnancies are ectopic, indicating a significantly increased risk over the stated 10%.",
        "question": "What is the approximate rate of ectopic pregnancy among women who conceive after having one ectopic pregnancy?",
        "source": {
            "isbn": "978-0323653992",
            "page": 398,
            "paragraph_id": "978-0323653992-p398-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "About three-quarters of the women.",
        "false_answer": "Three-quarters of the women.",
        "incorrect_explanation": "According to the paragraph, approximately half of the women with ruptured ectopic pregnancy have less than 500 mL of hemoperitoneum, one-fourth have between 500 and 1000 mL, and one-fifth more than 1000 mL. Thus, stating three-quarters of the women have less than 500 mL incorrectly represents the distribution given in the paragraph.",
        "question": "What proportion of women experiencing ruptured ectopic pregnancy typically exhibit less than 500 mL of hemoperitoneum?",
        "source": {
            "isbn": "978-0323653992",
            "page": 402,
            "paragraph_id": "978-0323653992-p402-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 18.",
        "false_answer": "Approximately 18.",
        "incorrect_explanation": "According to the paragraph, the annual ectopic pregnancy rate per 10,000 women aged 15 to 44 in the United States in 1989 was 15.5, which is also noted to be similar to that in Finland. Therefore, stating approximately 18 is incorrect because there's no indication that Finland had this higher rate during that period, especially when compared directly against the US data given as 15.5 cases per 10,000 women.",
        "question": "What was the approximate annual ectopic pregnancy rate per 10,000 women aged 15 to 44 reported in Finland around the same time frame as 1989?",
        "source": {
            "isbn": "978-0323653992",
            "page": 395,
            "paragraph_id": "978-0323653992-p395-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The median time to ongoing pregnancy by natural conception after salpingectomy was 15 months.",
        "false_answer": "The median time to ongoing pregnancy by natural conception after salpingectomy was 15 months.",
        "incorrect_explanation": "According to the given data, the median time to ongoing pregnancy by natural conception after salpingectomy was actually reported to be 26 months (with a 95% confidence interval of 15 to 37), making the statement incorrect.",
        "question": "What is the median time to ongoing pregnancy by natural conception after salpingectomy?",
        "source": {
            "isbn": "978-0323653992",
            "page": 409,
            "paragraph_id": "978-0323653992-p409-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Single-dose methotrexate therapy is approximately 20% effective in resolving unruptured ectopic pregnancies without surgical intervention.",
        "false_answer": "Approximately 20% effective.",
        "incorrect_explanation": "Actual reported success rates are significantly higher when properly applied, commonly ranging between 70% to over 90%.\n- **Correct Answer Should Be:** Around 70-90% effective under proper conditions.",
        "question": "How effective is single-dose methotrexate therapy in treating unruptured ectopic pregnancies?",
        "source": {
            "isbn": "978-0323653992",
            "page": 417,
            "paragraph_id": "978-0323653992-p417-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Vulvar hemangiomas typically range in color from green to yellow.",
        "false_answer": "Vulvar hemangiomas typically range in color from green to yellow.",
        "incorrect_explanation": "According to the paragraph, vulvar hemangiomas usually range in color from brown to red or purple, not from green to yellow. Strawberry hemangiomas are bright red to dark red, and cavernous hemangiomas are usually purple, further contradicting the false answer.",
        "question": "What is the typical color range of vulvar hemangiomas?",
        "source": {
            "isbn": "978-0323653992",
            "page": 422,
            "paragraph_id": "978-0323653992-p422-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Vestibulodynia typically affects women over the age of 50.",
        "false_answer": "Vestibulodynia typically occurs in women over the age of 50.",
        "incorrect_explanation": "According to the information given, vestibulodynia is found in younger women, most commonly white, with onset shortly after puberty through the mid-20s. Therefore, the statement that it typically affects women over the age of 50 is incorrect because this description aligns more closely with dysesthetic vulvodynia, which is said to affect peri- and postmenopausal women who rarely had previous vulvar pain.",
        "question": "What age group does vestibulodynia most commonly occur in?",
        "source": {
            "isbn": "978-0323653992",
            "page": 429,
            "paragraph_id": "978-0323653992-p429-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 5 in 50 women develop these cysts.",
        "false_answer": "Approximately 5 in 50 women develop these cysts.",
        "incorrect_explanation": "According to the given text, approximately 1 in 200 women develop vaginal cysts, making the statement that 5 in 50 women do so both inaccurate and significantly higher than reported.",
        "question": "What is the approximate incidence rate at which women develop vaginal cysts?",
        "source": {
            "isbn": "978-0323653992",
            "page": 433,
            "paragraph_id": "978-0323653992-p433-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "6 mm",
        "false_answer": "6 mm",
        "incorrect_explanation": "According to the text, the normal endometrial thickness is actually 4 mm or less in a postmenopausal woman not taking hormones.\n- **Correct Answer Should Be:** 4 mm or less",
        "question": "What is considered the normal maximum endometrial thickness in a postmenopausal woman who does not take hormones?",
        "source": {
            "isbn": "978-0323653992",
            "page": 437,
            "paragraph_id": "978-0323653992-p437-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Eighty percent of uterine leiomyomas have normal chromosomal abnormalities.",
        "false_answer": "Eighty percent of uterine leiomyomas have normal chromosomal abnormalities.",
        "incorrect_explanation": "According to the paragraph, sixty percent of uterine leiomyomas are normal, with a 46XX karyotype, not eighty percent.",
        "question": "What percentage of uterine leiomyomas have normal chromosomal abnormalities, specifically 46XX?",
        "source": {
            "isbn": "978-0323653992",
            "page": 442,
            "paragraph_id": "978-0323653992-p442-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "A simple cyst larger than 15 cm in a perimenopausal woman may usually be safely observed.",
        "false_answer": "A simple cyst larger than 15 cm in a perimenopausal woman may usually be safely observed.",
        "incorrect_explanation": "According to general guidelines, any cyst showing complexity, persistence, or exceeding a size threshold (typically around 10 cm) warrants evaluation beyond observation alone, regardless of being simple. Thus, stating that a cyst over 15 cm can be safely observed overlooks these critical considerations.",
        "question": "What size simple cyst in a perimenopausal woman can typically be observed instead of immediately surgically evaluated?",
        "source": {
            "isbn": "978-0323653992",
            "page": 454,
            "paragraph_id": "978-0323653992-p454-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The genetic heritability of endometriosis has been estimated at 72% based on twin studies.",
        "false_answer": "72%",
        "incorrect_explanation": "The estimate of 72% is incorrect because according to the paragraph, the genetic heritability of endometriosis was actually estimated at 52% based on twin studies (Treloar, 1999).",
        "question": "What is the estimated genetic heritability of endometriosis based on twin studies?",
        "source": {
            "isbn": "978-0323653992",
            "page": 475,
            "paragraph_id": "978-0323653992-p475-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 20% of women with extensive endometriosis are asymptomatic.",
        "false_answer": "Approximately 20% of women with extensive endometriosis are asymptomatic.",
        "incorrect_explanation": "The statement given does not address the actual query regarding the percentage of women experiencing severe episodes of pain. Instead, it incorrectly implies that being asymptomatic equates to having severe pain, which is misleading according to the paragraph's discussion on variability in symptoms among patients with endometriosis. Furthermore, the paragraph actually suggests that there is an inverse relationship between the extent of pelvic endometriosis and the severity of pelvic pain, indicating that some individuals with minimal implants can experience incapacitating chronic pain, whereas those with more extensive endometriosis might remain asymptomatic. Therefore, the provided answer neither accurately reflects the distribution nor addresses the inquiry concerning severe pain experiences among these patients correctly.",
        "question": "What percentage of women diagnosed with endometriosis experience severe episodes of pain?",
        "source": {
            "isbn": "978-0323653992",
            "page": 472,
            "paragraph_id": "978-0323653992-p472-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 95% of patients show significant symptom relief.",
        "false_answer": "Approximately 95% of patients show significant symptom relief.",
        "incorrect_explanation": "According to the given paragraph, GnRH agonist therapy actually improves symptoms in 75% to 90% of patients with endometriosis, depending on the extent of the disease in the study group. Therefore, stating that approximately 95% of patients experience improvement is an overstatement.",
        "question": "What percentage of patients with endometriosis experience improvement in their symptoms when treated with GnRH agonist therapy?",
        "source": {
            "isbn": "978-0323653992",
            "page": 483,
            "paragraph_id": "978-0323653992-p483-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The fascial defect is located in the peritoneum.",
        "false_answer": "The fascial defect is located in the peritoneum.",
        "incorrect_explanation": "According to the description of layers involved in umbilical hernia repair, the fascial defect is actually associated with the area outside the peritoneum, involving structures like the rectus abdominis muscle and pre-peritoneal space, rather than being within the peritoneum itself. The correct understanding involves recognizing the distinction between these anatomical spaces and their roles in herniation and surgical repair.",
        "question": "What layer is the fascial defect located in during an umbilical hernia repair?",
        "source": {
            "isbn": "978-0323653992",
            "page": 499,
            "paragraph_id": "978-0323653992-p499-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The revised American Fertility Society classification of endometriosis was published in 1992.",
        "false_answer": "The revised American Fertility Society classification of endometriosis was published in 1992.",
        "incorrect_explanation": "The paragraph actually mentions the publication regarding the reproducibility of scoring for the revised American Fertility Society classification of endometriosis being in 1995, specifically citing e5Rock JA et al.'s work titled \"Zoladex Endometriosis Study Group: the revised American Fertility Society classification of endometriosis: reproducibility of scoring. Fertil Steril. 1995;63:1108.\" Therefore, the correct answer should reflect this accurate timing.",
        "question": "What year was the revised American Fertility Society classification of endometriosis published?",
        "source": {
            "isbn": "978-0323653992",
            "page": 494,
            "paragraph_id": "978-0323653992-p494-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "They published these findings in 2013.",
        "false_answer": "2013",
        "incorrect_explanation": "According to the given sources, Evans-Hoeker actually published their findings on endometrial BCL6 overexpression in eutopic endometrium of women with endometriosis in 2016, not 2013.\n- **Correct Answer Should Be:** 2016",
        "question": "What year did Evans-Hoeker publish their findings regarding endometrial BCL6 overexpression?",
        "source": {
            "isbn": "978-0323653992",
            "page": 490,
            "paragraph_id": "978-0323653992-p490-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Abdominal hysterectomy is suggested by the American College of Obstetricians and Gynecologists to have better outcomes and fewer complications.",
        "false_answer": "Abdominal hysterectomy is suggested by the American College of Obstetricians and Gynecologists to have better outcomes and fewer complications.",
        "incorrect_explanation": "The paragraph actually states that according to the American College of Obstetricians and Gynecologists' committee opinion and a Cochrane systematic review (2015), vaginal hysterectomy is associated with better outcomes and fewer complications than laparoscopic or abdominal hysterectomy.",
        "question": "What type of surgical procedure does the American College of Obstetricians and Gynecologists suggest is associated with better outcomes and fewer complications compared to laparoscopic or abdominal hysterectomy?",
        "source": {
            "isbn": "978-0323653992",
            "page": 519,
            "paragraph_id": "978-0323653992-p519-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Measuring pelvic organ prolapse is best done with the patient lying down.",
        "false_answer": "Measuring pelvic organ prolapse is best done with the patient lying down.",
        "incorrect_explanation": "According to the given information, the maximum prolapse is more likely to be observed with a full bladder in the standing position at the end of the day. Therefore, the statement that measuring pelvic organ prolapse is best done with the patient lying down is incorrect because it does not specify conditions under which the maximum bulge can occur, particularly missing the point about standing being potentially better for observing the maximum effect.",
        "question": "What method is recommended for measuring pelvic organ prolapse when a full bladder is most likely to reproduce the maximum bulge?",
        "source": {
            "isbn": "978-0323653992",
            "page": 504,
            "paragraph_id": "978-0323653992-p504-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "About half of the women surveyed expressed desire for uterine preservation.",
        "false_answer": "Approximately half of the women surveyed desired uterine preservation.",
        "incorrect_explanation": "According to the given information, studies suggest that about a third of women wish for uterine preservation even when done with child-bearing, which directly contradicts the claim made in the false answer.",
        "question": "What proportion of women wish for uterine preservation even when they're done with childbearing?",
        "source": {
            "isbn": "978-0323653992",
            "page": 523,
            "paragraph_id": "978-0323653992-p523-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 25% of women will have a third episode.",
        "false_answer": "Approximately 25% of women will have a third episode.",
        "incorrect_explanation": "According to the paragraph, 50% of women who have had two UTIs in 6 months will have a third episode, making the statement significantly underestimating the recurrence rate.",
        "question": "What percentage of women will experience a recurrent UTI after having two UTIs in six months?",
        "source": {
            "isbn": "978-0323653992",
            "page": 540,
            "paragraph_id": "978-0323653992-p540-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The submucosal arteriovenous complex of the urethra is estimated to contribute 50% of the forces responsible for continence.",
        "false_answer": "50%",
        "incorrect_explanation": "The paragraph actually estimates that the submucosal arteriovenous complex of the urethra contributes 30% of the forces responsible for continence, not 50%.",
        "question": "What percentage of the forces responsible for continence in females is estimated to be contributed by the submucosal arteriovenous complex of the urethra?",
        "source": {
            "isbn": "978-0323653992",
            "page": 533,
            "paragraph_id": "978-0323653992-p533-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "A 30-degree lens is best for examining the urethra.",
        "false_answer": "A 30-degree lens is best for examining the urethra.",
        "incorrect_explanation": "According to the information, a 0- or 12-degree lens is actually best for examining the urethra, not a 30-degree lens. The 30-degree lens is used for other procedures such as catheterizing a ureteral orifice or taking a biopsy.",
        "question": "What degree lens is recommended for examining the urethra during a cystoscopy procedure?",
        "source": {
            "isbn": "978-0323653992",
            "page": 538,
            "paragraph_id": "978-0323653992-p538-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 10% to 15% of patients have urinary incontinence.",
        "false_answer": "Approximately 10% to 15% of patients have urinary incontinence.",
        "incorrect_explanation": "According to the provided information, actually 35% to 50% of patients with urethral diverticulum experience urinary incontinence, not 10% to 15%.",
        "question": "What proportion of patients with urethral diverticulum experience urinary incontinence?",
        "source": {
            "isbn": "978-0323653992",
            "page": 546,
            "paragraph_id": "978-0323653992-p546-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "About 75%.",
        "false_answer": "Approximately 75%.",
        "incorrect_explanation": "According to Sokol (2014), the actual efficacy of these agents at about 1 year was around 50%. Therefore, stating an efficacy of approximately 75% is incorrect.",
        "question": "What was the approximate efficacy of periurethral bulking agents made with collagen at 1 year?",
        "source": {
            "isbn": "978-0323653992",
            "page": 552,
            "paragraph_id": "978-0323653992-p552-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The balloon is inflated in 20-cm3 increments.",
        "false_answer": "The balloon is inflated in 20-cm3 increments.",
        "incorrect_explanation": "According to the provided text, the balloon is placed in the rectum and inflated in 10-cm3 increments to determine rectal sensation and compliance, not in 20-cm3 increments.",
        "question": "What volume increments are typically used when inflating the balloon during anal manometry to determine rectal sensation?",
        "source": {
            "isbn": "978-0323653992",
            "page": 579,
            "paragraph_id": "978-0323653992-p579-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The study on intravesical botulinum toxin-A injections was published in 2015.",
        "false_answer": "2015",
        "incorrect_explanation": "The study by Kuo HC et al. on intravesical botulinum toxin-A injections to reduce bladder pain of interstitial cystitis/bladder pain syndrome was actually published in 2016, according to the given reference: \"Kuo HC.... Neurourol Urodyn. 2016;35:609\". Therefore, the correct publication year is 2016, not 2015.",
        "question": "What year was the study published regarding intravesical botulinum toxin-A injections for reducing bladder pain in interstitial cystitis/bladder pain syndrome?",
        "source": {
            "isbn": "978-0323653992",
            "page": 563,
            "paragraph_id": "978-0323653992-p563-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Rapid serologic point-of-care tests are the most specific method for detecting antibodies to herpes.",
        "false_answer": "Rapid serologic point-of-care tests are the most specific method for detecting antibodies to herpes.",
        "incorrect_explanation": "The paragraph actually states that testing for antibodies to herpes is the most specific method but notes it's not widely available and difficult to perform. Specifically, enzyme-linked immunoassay (ELIA) and immunoblot tests are mentioned as available methods, with rapid serologic point-of-care tests being available for HSV-2 antibodies, indicating they are one of several options rather than the sole most specific method.",
        "question": "What is the primary method for screening antibodies to herpes, according to the given information?",
        "source": {
            "isbn": "978-0323653992",
            "page": 598,
            "paragraph_id": "978-0323653992-p598-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Cholestyramine is prescribed at 20 grams daily.",
        "false_answer": "Cholestyramine is prescribed at 20 grams daily.",
        "incorrect_explanation": "According to Table 22.7, Cholestyramine's dosage ranges from 4 to 36 grams per day, divided into 1 to 4 doses, starting with an increase of 4 grams weekly, rather than being fixed at 20 grams daily.",
        "question": "What dosage of Cholestyramine is recommended?",
        "source": {
            "isbn": "978-0323653992",
            "page": 585,
            "paragraph_id": "978-0323653992-p585-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 80% of patients.",
        "false_answer": "Approximately 80% of patients.",
        "incorrect_explanation": "According to the given paragraph, the actual success rate for curing fistulas caused by Crohn's disease using rectal advancement flaps was 60%, not 80%.\n- **Correct Answer Should Be:** Around 60%.",
        "question": "What percentage of patients with fistulas caused by Crohn's disease were successfully cured using rectal advancement flaps at the Cleveland Clinic?",
        "source": {
            "isbn": "978-0323653992",
            "page": 588,
            "paragraph_id": "978-0323653992-p588-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "The recommended dosage of benzathine penicillin G for treating early syphilis is 1.8 million units IM, given in two doses.",
        "false_answer": "The recommended dosage of benzathine penicillin G for treating early syphilis is 1.8 million units IM, given in two doses.",
        "incorrect_explanation": "According to the paragraph, specifically BOX 23.1, the recommended regimen for early syphilis is benzathine penicillin G, 2.4 million units IM, administered in one dose. Therefore, the correct answer should state 2.4 million units IM, not 1.8 million units, and specify one dose instead of two.",
        "question": "What is the recommended dosage of benzathine penicillin G for treating early syphilis?",
        "source": {
            "isbn": "978-0323653992",
            "page": 603,
            "paragraph_id": "978-0323653992-p603-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "They published this study in 1990.",
        "false_answer": "1990",
        "incorrect_explanation": "The publication year given in the paragraph for the study by Sobel et al. regarding the comparison between single oral dose fluconazole and conventional clotrimazole topical therapy of Candida vaginitis was actually 1995, not 1990.",
        "question": "What year did Sobel et al. publish their study comparing single oral dose fluconazole with conventional clotrimazole topical therapy of Candida vaginitis?",
        "source": {
            "isbn": "978-0323653992",
            "page": 620,
            "paragraph_id": "978-0323653992-p620-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 2.5% of these tests demonstrated an abnormality.",
        "false_answer": "Approximately 2.5% of these tests demonstrated an abnormality.",
        "incorrect_explanation": "The study by Kaplan and colleagues actually found that only 0.22% of the routinely ordered preoperative tests demonstrated an abnormality that might influence perioperative management, not 2.5%.",
        "question": "What percentage of routinely ordered preoperative tests demonstrated an abnormality that might influence perioperative management according to Kaplan and colleagues?",
        "source": {
            "isbn": "978-0323653992",
            "page": 624,
            "paragraph_id": "978-0323653992-p624-para1"
        },
        "type": "short_inverse"
    },
    {
        "answer": "Approximately 5% incidence.",
        "false_answer": "Approximately 5% incidence of surgical site infections when patients were shaved before surgery.",
        "incorrect_explanation": "According to Cruse and Foord's study over approximately 63,000 operations, there was actually a reported 2.5% incidence of SSIs when patients were shaved, compared to 0.9% if they weren't shaved. Therefore, the given answer incorrectly inflates this number significantly.\n- **Correct Information Based on Paragraph:** The actual incidence rates observed by Cruse and Foord were 2.5% for those who were shaved versus 0.9% for those who were not shaved.",
        "question": "What was the approximate incidence of surgical site infections when patients were shaved before surgery according to Cruse and Foord's study?",
        "source": {
            "isbn": "978-0323653992",
            "page": 630,
            "paragraph_id": "978-0323653992-p630-para1"
        },
        "type": "short_inverse"
    }
]